Identification of mutations by ultra-deep sequencing may help predict nilotinib response in CML-CP patientsNovember 30, 2021CML
Routine monitoring of imatinib plasma levels may help decide clinical course in CMLNovember 30, 2021CML
Frontline dasatinib therapy is effective and well tolerated in older patients with CML-CPOctober 24, 2021CML
Ten-year follow-up continue to support nilotinib in Japanese patients with newly diagnosed CML-CPOctober 24, 2021CML
CML-CP: Elevated creatine kinase levels during first-line TKI treatment associated with improved survivalOctober 24, 2021CML
